ClinicalTrials.gg
CompletedNCT02613533Updated Nov 30, 2017

Water Drinking Test in Patients With Occludable Angle

An interventional study of Intra-ocular pressure measurement (IOP) in Glaucoma, sponsored by Wills Eye. Completed at 1 site in United States. Open to participants aged 21 Years to 90 Years. Per ClinicalTrials.gov, last updated 2017-11-30.

Sponsored by Wills Eye · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
21 Years to 90 Years
Sex
All
01

Study summary

The water drinking test (WDT), is a predictive test that has been used to detect primary open angle glaucoma and recently has been demonstrated as a predictor of the diurnal tension curve. Clinically accurate provocative tests for asymptomatic eyes with shallow anterior chambers and narrow angles are highly desirable to detect patients prone to angle closure glaucoma. The aim of this pilot study is to evaluate the possible role of water drinking test in patients with narrow angles who are scheduled for prophylactic laser iridotomy.

Read the detailed description

This prospective case series will investigate the effects of the WDT on subjects with narrow anterior chamber angles on the day of their scheduled laser iridotomy. The angle configuration and IOP will be monitored following the WDT. Twenty patients with occludable angles will be enrolled in this study. After measuring the baseline IOP, weight and height, the patients will be asked to drink 10ml/kg water over 15 minutes (equal to approximately 0.33 ounces of water for every 2.2 pounds of weight or 2 ½ cups for a 150 lb. individual) and their IOP will be checked every 15 minutes up to one hour after drinking the water. This will be repeated after performing a laser iridotomy. The data obtained, mainly IOP and gonioscopic findings, will be analyzed using statistical tests and compared to historical controls of the WDT without narrow angles, and laser iridotomy subjects without the WDT.

02

Conditions studied

  • Glaucoma

Browse trials for

03

In context

Glaucoma

1,844 studies on the registry are indexed under Glaucoma; 233 are open to participants now.

This study's enrollment of 20 is below the median of 65 across 1,296 interventional studies indexed under Glaucoma.

Browse Glaucoma studies →

Lead sponsor

Wills Eye is the lead sponsor of 77 studies on the registry; 2 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 10 (83%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • narrow angle judged to be at risk of attack by the treating physician, with one or more quadrants not open to the sclera spur on gonioscopy
  • age between 21 and 90 years
  • ability to give informed consent.

Exclusion criteria

Exclusion Criteria:

  • baseline IOP higher than 21 mm Hg with or without medication
  • other causes of glaucoma, such as pseudoexfoliative and pigmentary glaucomas
  • previous treatment with argon laser or selective laser trabeculoplasty
  • previous refractive sugary; (5) pregnant women; (6) congestive heart failure
  • renal failure or urinary retention issues; (8) corneal abnormalities preventing reliable IOP measurement
  • non-glaucomatous optic neuropathy
  • prior refractive surgery or other issues preventing accurate Goldmann applanation tonometry
  • prior intraocular surgery
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Narrow Angle Glaucoma Study Group

    Subjects will be given 10ml/kg of water over 15 min prior to surgery and Intra-ocular pressure measurement (IOP) is checked every 15 min before and after surgical procedure.

    Other: Intra-ocular pressure measurement (IOP)

Interventions

  • OtherIntra-ocular pressure measurement (IOP)

    Subjects will be given 10ml/kg of water over 15 min prior to laser peripheral iridotomy (LPI) surgery and Intra-ocular pressure (IOP) is tested every 15 min before and after surgical procedure

06

What researchers measure

Primary outcomes

  1. Intra-ocular pressure measurement

    Twenty patients with occludable angles will be enrolled in this study. After measuring the baseline Intra-ocular pressure, weight and height, the patients will be asked to drink 10ml/kg water over 15 minutes (equal to approximately 2 ½ cups for a 150 lb. individual) and their intra-ocular pressure (IOP) will be checked every 15 minutes up to one hour after drinking the water. This will be repeated after performing a laser peripheral iridotomy (LPI). The data obtained, mainly Intra-ocular pressure will be analyzed using statistical tests and compared to historical controls of the WDT without narrow angles, and laser iridotomy subjects without the WDT.

    Time frame: every 15 minutes before and after surgery for upto an hour

07

Study locations

1 site
  • Wills Eye Institute
    Philadelphia, Pennsylvania 19107, United States
08

References and documents

Individual participant data

Plan to share: No — A manuscript has been accepted for publication in Patient Preference and Adherence.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 30, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02613533
Lead sponsor
Wills Eye
Responsible party
Jonathon Myers (Principle Investigator, Wills Eye) — Principal investigator
First posted
Nov 24, 2015
Start date
Feb 2010
Primary completion
Jan 2015
Completion
Jan 2015
Last update
Nov 30, 2017

Study contacts

Jonathan Myers, MD
principal investigator · Wills Eye

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion